» Articles » PMID: 33383373

Alpiniae Oxyphyllae Fructus and Alzheimer's Disease: An Update and Current Perspective on This Traditional Chinese Medicine

Overview
Date 2020 Dec 31
PMID 33383373
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a common progressive neuro-degenerative disease, and the morbidity and mortality are still on the rise. In spite of recent advances in AD treatment, their clinical efficacy has been limited, non-curative and easy to drug resistance. Alpiniae oxyphyllae Fructus (AOF), derived from the dried and mature fruits of the Zingiberaceae plant Alpinia oxyphylla Miq, is a choice in traditional Chinese medicine to treat AD, which has a good effect and has been used for a long time. Recent studies have demonstrated its potent activities in modulating multiple signaling pathways associated with β-amyloid deposition, tau protein phosphorylation, chronic inflammation, oxidative stress. The neuropharmacological mechanism of AOF in AD have been fully illustrated in numerous studies. In this review, we first briefly described the active components of AOF and related mechanism for treating AD. And we also provide a systematic overview of recent progress on the pharmacokinetic characteristics of the active ingredients of AOF and analyzed their bioavailability differences in the development of AD. Thus, AOF hold a great therapeutic potential in the treatment of AD and is worthy of further research and promotion.

Citing Articles

Network Pharmacology, Molecular Docking, and In Vitro Insights into the Potential of for Alzheimer's Disease.

Hossain R, Noonong K, Nuinoon M, Majima H, Eawsakul K, Sompol P Int J Mol Sci. 2024; 25(23).

PMID: 39684911 PMC: 11642099. DOI: 10.3390/ijms252313201.


NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer's disease.

Hu B, Zhang J, Huang J, Luo B, Zeng X, Jia J Neural Regen Res. 2024; 19(11):2400-2410.

PMID: 38526276 PMC: 11090449. DOI: 10.4103/1673-5374.391311.


Identification of in the Potential Treatment of Alzheimer's Disease by Integrating Virtual Screening and In Vitro Validation.

Jiang S, Borjigin G, Sun J, Li Q, Wang Q, Mu Y Int J Mol Sci. 2023; 24(20).

PMID: 37895137 PMC: 10607254. DOI: 10.3390/ijms242015457.


1,7-diphenyl-4-hepten-3-one mitigates Alzheimer's-like pathology by inhibiting pyroptosis via activating the Nrf2 pathway.

Shi Y, Zhang Y, Luo X, Yang H, He Y Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):3065-3075.

PMID: 37878046 DOI: 10.1007/s00210-023-02765-2.


Chromosome-level genome and multi-omics analyses provide insights into the geo-herbalism properties of .

Pan K, Dai S, Tian J, Zhang J, Liu J, Li M Front Plant Sci. 2023; 14:1161257.

PMID: 37360712 PMC: 10285302. DOI: 10.3389/fpls.2023.1161257.